Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage

The purpose of this study was to evaluate the 1-year visual outcomes of patients treated with intravitreal aflibercept (IVA) or brolucizumab (IVBr) for submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (AMD). We retrospectively studied 62 treatment-naïve eyes with...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruyama-Inoue, Maiko, Kitajima, Yoko, Yanagi, Yasuo, Inoue, Tatsuya, Kadonosono, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081992/
https://www.ncbi.nlm.nih.gov/pubmed/37029159
http://dx.doi.org/10.1038/s41598-023-32874-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081992/
https://www.ncbi.nlm.nih.gov/pubmed/37029159
http://dx.doi.org/10.1038/s41598-023-32874-0

Ejemplares similares